Climb Bio Inc.

4 trials 2 recruiting Commercial sponsor

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

0 Completed trials

4 Countries active

1 Unique IMPs

N/A Results reported

Phase I/II

Phase I (Other)

Phase I/II: 2 Phase I (Other): 2

Top indications

Systemic lupus erythematosus 2

Top IMPs

All trials

4 total

A study to find how well budoprutug (TNT119) works and how safe it is in participants with immune thrombocytopenia Not authorised

2024-519745-30-00 Phase I/II 3 countries BUDOPRUTUG
A study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus Not authorised

2024-520385-57-00 Phase I (Other) 1 country
A study to find how well budoprutug (TNT119) works and how safe it is in participants with immune thrombocytopenia Recruiting

2024-519745-30-01 Phase I/II 3 countries BUDOPRUTUG
A study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus Recruiting

2024-520385-57-01 Phase I (Other) 4 countries

Showing 1–4 of 4 trials

← All sponsors A–Z